Instant effect of soluble antigen on effector T cells in peripheral immune organs during immunotherapy of autoimmune encephalomyelitis
暂无分享,去创建一个
H. Lassmann | H. Wekerle | J. Ellwart | A. Flügel | N. Kawakami | F. Odoardi | C. Cordiglieri | J. Bauer | W. Klinkert | M. Nosov | Zhaoxia Li | K. Streyl
[1] R. Mebius,et al. Structure and function of the spleen , 2005, Nature Reviews Immunology.
[2] H. Lassmann,et al. Autoimmune CD4+ T Cell Memory: Lifelong Persistence of Encephalitogenic T Cell Clones in Healthy Immune Repertoires 1 , 2005, The Journal of Immunology.
[3] Tobias Bonhoeffer,et al. Live imaging of effector cell trafficking and autoantigen recognition within the unfolding autoimmune encephalomyelitis lesion , 2005, The Journal of experimental medicine.
[4] Michael Sixt,et al. The conduit system transports soluble antigens from the afferent lymph to resident dendritic cells in the T cell area of the lymph node. , 2005, Immunity.
[5] Ira Mellman,et al. Cell biology of antigen processing in vitro and in vivo. , 2005, Annual review of immunology.
[6] R. Hohlfeld,et al. Autoimmune concepts of multiple sclerosis as a basis for selective immunotherapy: From pipe dreams to (therapeutic) pipelines , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[7] Michael D. Cahalan,et al. Imaging the Single Cell Dynamics of CD4+ T Cell Activation by Dendritic Cells in Lymph Nodes , 2004, The Journal of experimental medicine.
[8] Marc K Jenkins,et al. Visualizing the first 50 hr of the primary immune response to a soluble antigen. , 2004, Immunity.
[9] L. Fetler,et al. Requirement of Rac1 and Rac2 Expression by Mature Dendritic Cells for T Cell Priming , 2004, Science.
[10] A. Trautmann,et al. ERM proteins regulate cytoskeleton relaxation promoting T cell–APC conjugation , 2004, Nature Immunology.
[11] R. Ransohoff,et al. The Activation Status of Neuroantigen-specific T Cells in the Target Organ Determines the Clinical Outcome of Autoimmune Encephalomyelitis , 2004, The Journal of experimental medicine.
[12] S. Henrickson,et al. T-cell priming by dendritic cells in lymph nodes occurs in three distinct phases , 2004, Nature.
[13] P. Delmotte,et al. Failure of basic protein therapy for multiple sclerosis , 1977, Journal of Neurology.
[14] Lawrence Steinman,et al. Protein microarrays guide tolerizing DNA vaccine treatment of autoimmune encephalomyelitis , 2003, Nature Biotechnology.
[15] M. Nolte,et al. A Conduit System Distributes Chemokines and Small Blood-borne Molecules through the Splenic White Pulp , 2003, The Journal of experimental medicine.
[16] R. Ransohoff,et al. Three or more routes for leukocyte migration into the central nervous system , 2003, Nature Reviews Immunology.
[17] Mark J. Miller,et al. Autonomous T cell trafficking examined in vivo with intravital two-photon microscopy , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[18] A. Ben-nun,et al. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene. , 2002, The Journal of clinical investigation.
[19] Mark J. Miller,et al. Two-Photon Imaging of Lymphocyte Motility and Antigen Response in Intact Lymph Node , 2002, Science.
[20] W. Paul,et al. Antigen challenge leads to in vivo activation and elimination of highly polarized TH1 memory T cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[21] S. Miller,et al. Epitope spreading in immune-mediated diseases: implications for immunotherapy , 2002, Nature Reviews Immunology.
[22] Boris Barbour,et al. Functional antigen-independent synapses formed between T cells and dendritic cells , 2001, Nature Immunology.
[23] A. Khoruts,et al. Single-cell analysis of signal transduction in CD4 T cells stimulated by antigen in vivo , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Lassmann,et al. Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis. , 2001, Immunity.
[25] R. Pedotti,et al. An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide , 2001, Nature Immunology.
[26] Joseph Frank,et al. Effective Antigen-Specific Immunotherapy in the Marmoset Model of Multiple Sclerosis , 2001, The Journal of Immunology.
[27] C. Reis e Sousa,et al. Microbial and T Cell-Derived Stimuli Regulate Antigen Presentation by Dendritic Cells In Vivo1 , 2000, The Journal of Immunology.
[28] A. Evans,et al. Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial , 2000, Nature Medicine.
[29] J. Frank,et al. Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.
[30] H. Wekerle,et al. Gene transfer into CD4+ T lymphocytes: Green fluorescent protein-engineered, encephalitogenic T cells illuminate brain autoimmune responses , 1999, Nature Medicine.
[31] Jide Tian,et al. Antigen-based immunotherapy for autoimmune disease: from animal models to humans? , 1999, Immunology today.
[32] P. Negulescu,et al. Polarity of T cell shape, motility, and sensitivity to antigen. , 1996, Immunity.
[33] H. Lassmann,et al. The N-terminal domain of the myelin oligodendrocyte glycoprotein (MOG) induces acute demyelinating experimental autoimmune encephalomyelitis in the Lewis rat , 1995, Journal of Neuroimmunology.
[34] G. Rodriguez,et al. Destructive proteolysis by cysteine proteases in antigen presentation of ovalbumin , 1995, European journal of immunology.
[35] J. Goverman,et al. T cell deletion in high antigen dose therapy of autoimmune encephalomyelitis. , 1994, Science.
[36] H. Geuze,et al. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells , 1992, The Journal of cell biology.
[37] A. Trautmann,et al. Imaging early steps of human T cell activation by antigen-presenting cells. , 1992, Journal of immunology.
[38] W. Hickey,et al. T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.
[39] H. Lassmann,et al. Cellular immune reactivity within the CNS , 1986, Trends in Neurosciences.
[40] H. Grey,et al. Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing , 1983, The Journal of experimental medicine.
[41] R. Lorenz,et al. Myelin basic protein administration in multiple sclerosis. , 1973, Archives of neurology.
[42] S. Levine,et al. Allergic Encephalomyelitis: Passive Transfer Prevented by Encephalitogen , 1968, Science.